Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

CYP2D-related Metabolism in Animals of the Canoidea Superfamily – Species Differences

Ishizuka, M., Lee, J.J., Masuda, M., Akahori, F., Kazusaka, A. and Fujita, S., 2006. CYP2D-related metabolism in animals of the Canoidea superfamily – species differences. Veterinary Research Communications, 30(5), 505–512

  • 68 Accesses

  • 4 Citations

Abstract

CYP2D-related drug metabolism in liver microsomes from animals of the Canoidea super family, i.e. mink (Mustela vison), bears (Ursus arctos), foxes (Vulpes vulpes) and dogs, were investigated. Propranolol, bunitrolol and imipramine, which are typically substrates of CYP2D subfamilies, were used in the experiment. All the animals of the Canoidea superfamily that were tested lacked the ability to catalyse 7-hydroxylation of propranolol, which is one of the major metabolic pathways in rats. Stereoselectivity of propranolol metabolism was towards (S)-propranolol in all the reactions of the animals tested with the exception of mink, which showed a selective tendency towards (R)-propranolol in {N-}dealkylation. As far as metabolic patterns of (R)- and (S)-propranolol are concerned, bears, foxes and dogs are alike, but minks are somewhat different. Liver microsomes from mink showed, among the animals of the Canoidea superfamily, the lowest propranolol hydroxylase activity at 4- and 5-positions and imipramine 2-hydroxylation and {N-}demethylation activities. We could not detect bunitrolol 4-hydroxylation in mink liver microsomes at the low substrate concentration used. We conclude that mink have the lowest activity of CYP2D-related xenobiotic metabolism among the Canoidea superfamily.

This is a preview of subscription content, log in to check access.

Abbreviations

CYP:

cytochrome P450

HPLC:

high-performance liquid chromatography

NADPH:

nicotinamide–adenine dinucleotide phosphate reduced form

References

  1. Fujita, S., Umeda, S., Funae, Y., Imaoka, S., Abe, H., Ishida, R., Adachi, T., Masuda, M., Kazusaka, A. and Suzuki, T., 1993. Regio- and stereoselective propranolol metabolism by 15 forms of purified cytochrome P450 from rat liver. Journal of Pharmacology and Experimental Therapeutics, 264, 226–233

  2. Guttendorf, R.J., Kostenbauder, H.B. and Wedlund, P.J., 1991. Stereoselective differences in propranolol disposition in female Sprague–Dawley and Dark Agouti rats. Drug Metabolism and Disposition, 19, 251–256

  3. Lowry, O.H., Rosebrough, N.J., Farr, L. and Randall, R.J., 1951. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265–275

  4. Masubuchi, Y., Hosokawa, S., Horie, T., Suzuki, T., Ohmori, S., Kitada, M. and Narimatsu, S., 1994. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase. Drug Metabolism and Disposition, 22, 909–915

  5. Nakamura, A., Yamamoto, Y., Tasaki, T., Sugimoto, C., Masuda, M., Kazusaka, A. and Fujita, S., 1995a. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody. Drug Metabolism and Disposition, 23, 1268–1273

  6. Omura, T. and Sato, R., 1964. The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2385

  7. Silber, B. and Riegelman, S., 1980. Stereospecific assay for −- and +-propranolol in human and dog plasma. Journal of Pharmacology and Experimental Therapeutics, 215, 643–648

  8. Suzuki, T., Narimatsu, S., Fujita, S., Masubuchi, Y., Umeda, S., Imaoka, S. and Funae, Y, 1992. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats. Drug Metabolism and Disposition, 20, 367–373

  9. Tasaki, T., Iwata, H., Kazusaka, A. and Fujita, S., 1998. Regio- and stereoselectivity in propranolol metabolism by dog liver microsomes and the expressed dog CYP2D15. Journal of Biochemistry (Tokyo), 123, 747–751

  10. Walle., T. and Walle, U.K., 1979. Stereoselective oral bioavailability of +/−-propranolol in the dog. A GC-MS study using a stable isotope technique. Research Communications in Chemical Pathology and Pharmacology, 23, 453–464

Download references

Author information

Correspondence to S Fujita.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ishizuka, M., Lee, J.J., Masuda, M. et al. CYP2D-related Metabolism in Animals of the Canoidea Superfamily – Species Differences. Vet Res Commun 30, 505–512 (2006). https://doi.org/10.1007/s11259-006-3213-8

Download citation

Keywords

  • Canoidea
  • metabolism
  • propranolol
  • regioselectivity
  • species differences